Are psychedelic drug treatments seeing a comeback in psychiatry?
نویسندگان
چکیده
منابع مشابه
Psychiatry & the psychedelic drugs. Past, present & future
The classical psychedelic drugs, including psilocybin, lysergic acid diethylamide and mescaline, were used extensively in psychiatry before they were placed in Schedule I of the UN Convention on Drugs in 1967. Experimentation and clinical trials undertaken prior to legal sanction suggest that they are not helpful for those with established psychotic disorders and should be avoided in those liab...
متن کاملHospital gardens are making a comeback.
Visitors to London’s Great Ormond Street Hospital may be in for a lovely surprise. Those who venture past the Peter Pan statue at the entrance, through the busy corridors, and into the middle of the hospital will eventually discover a little garden, secreted away from the hustle and bustle. Built on an abandoned boilerhouse roof, it is now a small retreat—quiet, peaceful, and sheltered. It is s...
متن کاملLatin American Psychopharmacology Update: INNOVATIVE TREATMENTS IN PSYCHIATRY INNOVATIVE TREATMENTS IN PSYCHIATRY
Metadoxine (pyridoxol L-2-pyrrolidone-5-carboxylate) is an ion-pair salt of pyridoxine (vitamin B6) and 2-pyrrolidone-5-carboxylate (PCA, also known as L-PGA). Metadoxine modulates GABAergic activity, and does not increase levels of brain neurotransmitterssuch as dopamine, norepinephrine and serotonin. In animal studies, Metadoxine has shown no signs of abuse or addiction potential....
متن کاملUnifying Theories of Psychedelic Drug Effects
How do psychedelic drugs produce their characteristic range of acute effects in perception, emotion, cognition, and sense of self? How do these effects relate to the clinical efficacy of psychedelic-assisted therapies? Efforts to understand psychedelic phenomena date back more than a century in Western science. In this article I review theories of psychedelic drug effects and highlight key conc...
متن کاملCan psychedelic compounds play a part in drug dependence therapy?
After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research this area.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Progress in Neurology and Psychiatry
سال: 2008
ISSN: 1367-7543,1931-227X
DOI: 10.1002/pnp.94